Riding high on Covid-19 vaccine success, FDA boosts mRNA vaccine reviews
In 2023, a record nine review designations were awarded to mRNA vaccines for eight different conditions, reflecting the FDA’s commitment to fostering broader applications of these vaccines
Business Today
6 days ago